NHS watchdog rejects use of party drug ketamine as antidepressant despite hype over treatment A radical depression treatment derived from party drug ketamine is set to be rejected for use on the NHS.
There has been months of hype over the treatment - the first antidepressant with a new mechanism of action to be licensed in 30 years.
But NICE say there is not enough evidence it works long-term, and the price - which exceeds £10,000 for the average course - is too high for the NHS to fund. The Daily Mail
No comments:
Post a Comment